daclizumab
General
**REMS Drug**
**Off Market Drug**
        This medication is no longer available in the United States. Information provided here is for reference purposes only.      
Pronunciation: 
dac-klye-zue-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Zinbryta
 
Ther. Class.
Pharm. Class.
interleukin antagonists
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Daclizumab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51191/all/daclizumab. 
Vallerand AHA, Sanoski CAC,  . Daclizumab. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51191/all/daclizumab. Accessed November 4, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Daclizumab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51191/all/daclizumab
Vallerand AHA, Sanoski CAC,  . Daclizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 November 04]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51191/all/daclizumab.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  daclizumab
ID  -  51191
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51191/all/daclizumab
PB  -  F.A. Davis Company
ET  -  19
DB  -  Pediatrics Central
DP  -  Unbound Medicine
ER  -  

Davis's Drug Guide

